Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo

Oncology Reports

Volumn 32, Issue 6, 2014, Pages 2411-2420

  Meng, Wei ^a   Wang, Pei Song ^a   Liu, Jia ^a   Xue, Shuai ^a   Wang, Gui Min ^a   Meng, Xian Ying ^a   Chen, Guang ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

NIN1 RPN12 binding protein 1 homolog; Papillary thyroid carcinoma; Radiosensitivity; Tumor growth

Indexed keywords

ADENOVIRUS VECTOR; BIOLOGICAL FACTOR; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NIN1 RPN12 BINDING PROTEIN 1 HOMOLOG; PROTEIN BCL 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; NOB1 PROTEIN, HUMAN; NUCLEAR PROTEIN; RNA BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL LINE TPC 1; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; ENZYME PHOSPHORYLATION; EXPRESSION VECTOR; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MIGRATION INHIBITION; MOUSE; NONHUMAN; PAPILLARY THYROID CARCINOMA CELL; RADIOSENSITIVITY; RNA INTERFERENCE; THYROID CARCINOMA; TUMOR XENOGRAFT; X IRRADIATION; ADENOVIRIDAE; ANIMAL; BAGG ALBINO MOUSE; CARCINOMA; CELL MOTION; CELL PROLIFERATION; DRUG SCREENING; GENE SILENCING; GENETICS; HEK293 CELL LINE; METABOLISM; MULTIMODALITY CANCER THERAPY; NUDE MOUSE; PATHOLOGY; RADIATION DOSE; THYROID NEOPLASMS; TUMOR CELL LINE; TUMOR INVASION; TUMOR VOLUME;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COMBINED MODALITY THERAPY; FEMALE; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RADIATION TOLERANCE; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; THYROID NEOPLASMS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84914705861     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3483     Document Type: Article

References (40)

1. Brown RL, de Souza JA and Cohen EE: Thyroid cancer: burden of illness and management of disease. J Cancer 2: 193-199, 2011.
2. Thompson L: World health Organization classification of tumours: pathology and genetics of head and neck tumours. Ear Nose Throat J 85: e74, 2006.
3. Nikiforova MN and Nikiforov YE: Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis. Expert Rev Mol Diagn 8: 83-95, 2008.
4. Dal Maso L, Bosetti C, La Vecchia C and Franceschi S: Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 20: 75-86, 2009
5. Jeong SY, Kim HW, Lee SW, Ahn BC and Lee J: Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms. Thyroid 23: 609-616, 2013.
6. Matuszczyk A, Petersenn S, Bockisch A, et al: Chemotherapy with doxorubicin in progressive medullary and thyroid carcinoma of the follicular epithelium. Horm Metab Res 40: 210-213, 2008.
7. Strasser JF, Raben A and Koprowski C: The role of radiation therapy in the management of thyroid cancer. Surg Oncol Clin N Am 17: 219-232, 2008.
8. Zhang Y, Ni J, Zhou G, et al: Cloning, expression and characterization of the human NOB1 gene. Mol Biol Rep 32: 185-189, 2005.
9. Makarova KS, Aravind L and Galperin MY: Comparative genomics of the Archaea (Euryarchaeota): evolution of conserved protein families, the stable core, and the variable shell. Genome Res 9: 608-628, 1999.
10. Arcus VL, Backbro K, Roos A, Daniel EL and Baker EN: Distant structural homology leads to the functional characterization of an archaeal PIN domain as an exonuclease. J Biol Chem 279: 16471-16478, 2008.
11. Lamanna AC and Karbstein K: Nob1 binds the signal-stranded cleavege site D at the 3'-end of 18S rRNA with its PIN domain. Proc Natl Acad Sci USA 106: 14259-14264, 2009.
12. Fatica A, Tollervey D and Dlakic M: PIN domain of Nob1p is required for D-site cleavage in 20S pre-rRNA. RNA 10: 1698-1701, 2004.
13. Fatica A, Oeffinger M, Dlakic M and Tollervey D: Nob1p is required for cleavage of the 3' end of 18S rRNA. Mol Cell Biol 23: 1798-1807, 2003.
14. Veith T, Martin R, Wurm J P, et al: Structural and functional analysis of the archaeal endonuclease Nob1. Nucleic Acids Res 40: 3259-3274, 2012.
15. Nazar RN: Ribosomal RNA processing and ribosome biogenesis in eukaryotes. IUBMB Life 56: 457-465, 2004.
16. Montanaro L, Trere D and Derenzini M: Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. Biochim Biophys Acta 1825: 101-110, 2012.
17. Hershko A and Ciechanover A: The ubiquitin system. Annu Rev Biochem 67: 425-479, 1998.
18. Ferrell K, Wilkinson CR, Dubiel W and Gordon C: Regulatory subunit interactions of the 26S proteasome, a complex problem. Trends Biochem Sci 25: 83-88, 2000.
19. Micel LN, Tentler JJ, Smith PG and Eckhardt GS: Role of ubiquitin ligases and the proteasome in oncogenesis: novel targets for anticancer therapies. J Clin Oncol 31: 1231-1238, 2013.
20. Mani A and Gelmann EP: The ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol 23: 4776-4789, 2005.
21. Lin Y, Peng S, Yu H, Teng H and Cui M: RNAi-mediated down-regulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells. Med Oncol 29: 311-317, 2012.
22. Che J P, Li W, Yan Y, et al: Expression and clinical significance of the nin one binding protein and p38 MAPK in prostate carcinoma. Int J Clin Exp Pathol 6: 2300-2311, 2013.
23. Li X Y, Luo QF, Li J, et al: Clinical significance of NOB1 expression in breast infiltrating ductal carcinoma. Int J Clin Exp Pathol 6: 2137-2144, 2013.
24. Li Y, Ma C, Qian M, Wen Z, Jing H and Qian D: Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo. Oncol Rep 31: 1271-1276, 2014.
25. Lin S, Meng W, Zhang W, et al: Expression of the NOB1 gene and its clinical significance in papillary thyroid carcinoma. J Int Med Res 41: 568-572, 2013.
26. Huang WY, Chen DH and Ning L: siRNA mediated silencing of NIN1/RPN12 binding protein 1 homolog inhibits proliferation and growth of breast cancer cells. Asian Pac J Cancer Prev 13: 1823-1827, 2012.
27. Lu Z, Guo Q, Shi A, Xie F and Lu Q: Down regulation of NIN/RPN12 binding protein inhibits the growth of human hepatocellular carcinoma cells. Mol Biol Rep 39: 501-507, 2012.
28. Guoan X, Hanning W, Kaiyun C and Hao L: Adenovirus-mediated siRNA targeting Mcl-1 gene increases radiosensitivity of pancreatic carcinoma cells in vitro and in vivo. Surgery 147: 553-561, 2010.
29. Yang J, Sun M, Zhang A, Lv C, De W and Wang Z: Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells. World J Surg Oncol 9: e117, 2011.
30. Lin CI, Whang EE, Donner DB, et al: Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer. Mol Cancer Res 7: 1655-1662, 2009.
31. Tone Y, Tanahashi N, Tanaka K, Fujimuro M, Yokosawa H and Toh-E A: Nob1p, a new essential protein, associates with the 26S proteasome of growing saccharomyces cerevisiae cells. Gene 243: 37-45, 2000.
32. Xu G, Bernaudo S, Fu G, Lee DY, Yang BB and Peng C: Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7. Mol Biol Cell 19: 4968-4979, 2008.
33. Fasanaro P, Capogrossi MC and Martelli F: Regulation of the endothelial cell cycle by the ubiquitin-proteasome system. Cardiovasc Res 85: 272-280, 2010.
34. Wang H, Li P and Zhao B: Knockdown of NOB1 expression by RNAi inhibits cellular proliferation and migration in human gliomas. Gene 528: 146-153, 2013.
35. Dhillon AS, Hagan S, Rath O and Kolch W: MAP kinase signalling pathways in cancer. Oncogene 26: 3279-3290, 2007.
36. Yacoub A, Mitchell C, Lebedeva I V, et al: mda-7 (IL-24) Inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling. Cancer Biol Ther 2: 347-353, 2003.
37. Chang L and Karin M: Mammalian MAP kinase signalling cascades. Nature 410: 37-40, 2001.
38. Sofia Vala I, Martins LR, Imaizumi N, et al: Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis. PLoS One 5: e11222, 2010.
39. Zhou J, Xu T, Yan Y, et al: MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1). PLoS One 8: e68469, 2013.
40. Wagner EF and Nebreda AR: Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549, 2009.